Dosage Lec - Module 1

0.0(0)
studied byStudied by 0 people
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/84

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

85 Terms

1
New cards

Container

Holds the pharmaceutical article and may be in direct contact with it

2
New cards

Immediate Container

Container that is in direct contact with the article at all times

3
New cards

Well-Closed Container

Protects contents from extraneous solids and from loss of article under ordinary conditions

4
New cards

Tight Container

Protects contents from contamination, loss, efflorescence, deliquescence, evaporation; capable of tight re-closure

5
New cards

Hermetic Container

Impervious to air or gas under normal handling, shipping, storage, and distribution

6
New cards

Examples of Hermetic Containers

Ampoules, vials, and glass containers sealed against air

7
New cards

Light-Resistant Container

Protects from light degradation by reducing transmission

8
New cards

Amber

Another term for light-resistant container

9
New cards

Light resistant opaque plastic

Plastic or glass that reduces light transmission for light-sensitive pharmaceuticals

10
New cards

UV Absorbers

Agents added to decrease transmission of short ultraviolet rays

11
New cards

USP Standard for Light Transmission

Not more than 10% transmission between 290–450 nm

12
New cards

Tamper-Evident Packaging

Packaging with one or more indicators/barriers to entry; if breached indicates tampering

13
New cards

Film Wrapper

Film sealed around product/container; film must be cut or torn

14
New cards

Blister Pack

Individually sealed dose units; requires tearing/breaking individual compartments

15
New cards

Bubble Pack

A kind of tamper evident packaging where product and container are sealed in plastic, usually mounted on display card; plastic must be cut or broken open to remove the product.

16
New cards

Shrink Seal

Plastic/film shrunk by heat/drying to conform to cap; must be torn to open

17
New cards

Pouch

Sealed individual packet; must be torn to reach product

18
New cards

Tape Seal

Paper/foil sealed over carton flap or bottle cap; must be torn/broken

19
New cards

Bottle Seal

Paper/foil sealed to mouth of container under cap

20
New cards

Breakable Cap

Plastic/metal cap that must be broken to remove

21
New cards

Tube Seal

Seal over mouth of tube; must be punctured

22
New cards

Carton Seal

Carton flaps sealed; cannot be opened without damage

23
New cards

Child-Resistant Container

Difficult for children <5 years to open or obtain harmful contents

24
New cards

Single-Dose Container

Holds a quantity of drug intended as single dose

25
New cards

Examples of Single-Dose Containers

Ampoules, prefilled syringes

26
New cards

Multiple-Dose Container

Permits withdrawal of successive portions without changing strength or purity

27
New cards

Example of Multiple-Dose Container

Multidose vial

28
New cards

Polyvinyl Chloride (PVC)

Rigid, good clarity, used in blister packs; unsuitable for gamma sterilization

29
New cards

Polypropylene, Polyethylene terephthalate (PET)

Plastics with excellent transparency and can be sterilized by gamma radiation

30
New cards

Glass Type I

Borosilicate glass, highly resistant, used for parenterals

31
New cards

Glass Type II

Treated soda-lime glass, resistant to water attack

32
New cards

Glass Type III

Soda-lime glass, suitable for dry powders

33
New cards

Glass Type NP

General-purpose soda-lime glass for non-parenteral use

34
New cards

Advantages of Plastic

Lightweight, unbreakable, variety of shapes, compatible with many drugs, low cost

35
New cards

Disadvantages of Plastic

Permeability, Leaching, Absorption, Light Exposure, Deformation

36
New cards

Cold Storage

Temperature not exceeding 8 °C

37
New cards

Refrigerated Storage

2–8 °C

38
New cards

Freezer Storage

-25 °C to -10 °C

39
New cards

Cool Storage

8–15 °C

40
New cards

Room Temperature

20–25 °C

41
New cards

Warm Temperature

30–40 °C

42
New cards

Excessive Heat

Above 40 °C

43
New cards

Master Formula

refers to the formulation that best meets the goals for a finished product.

44
New cards

Purity of Chemical Substance

Product appearance essential for evaluation of properties

45
New cards

Chemical Properties

Structure, form, reactivity

46
New cards

Physical Properties

Particle size, crystalline structure, melting point, solubility

47
New cards

Biologic Properties

Ability of drug to reach site of action and elicit response

48
New cards

Microscopic Examination

Indicates size distribution and crystalline form

49
New cards

Melting Point

Detects impurities; changes melting point and solubility

50
New cards

Phase Rule

Relates independent variables (temperature, pressure, concentration) to phases in equilibrium

51
New cards

Particle Size Effects

Influences dissolution rate, bioavailability, stability, sedimentation, flow

52
New cards

Polymorphism

Ability of drug to exist in different crystalline forms with different properties

53
New cards

Solubility

Drug must have adequate solubility for therapeutic effect

54
New cards

Dissolution Rate

Rate at which drug dissolves in absorption site fluids

55
New cards

Membrane Permeability

Drug must cross biologic membrane to act

56
New cards

Passive Diffusion

Process by which lipid-soluble drugs cross membranes

57
New cards

Partition Coefficient

Measure of drug lipophilicity

58
New cards

Stability Studies

Physical, chemical, biological stability evaluated before formulation

59
New cards

Hydrolysis

Drug breakdown due to reaction with water

60
New cards

Oxidation

Drug degradation due to loss of electrons

61
New cards

Stability

Extent product retains properties throughout storage period

62
New cards

Chemical Stability

Drug retains chemical integrity and potency

63
New cards

Physical Stability

Appearance, palatability, uniformity, dissolution, suspendability maintained

64
New cards

Microbiological Stability

Antimicrobial agents retain effectiveness

65
New cards

Therapeutic Stability

Therapeutic effect remains unchanged

66
New cards

Toxicological Stability

No significant increase in toxicity

67
New cards

Reasons for Stability Testing

Ensure efficacy, safety, shelf life

68
New cards

Antioxidants

Added to enhance stability against oxidation

69
New cards

Flavoring Agents

Mask taste; improve palatability

70
New cards

Sweet Flavors

Preferred by children

71
New cards

Tart Flavors

Preferred by adults

72
New cards

Cyclamate

Artificial sweetener banned by FDA in 1969 due to carcinogenicity concerns

73
New cards

Acesulfame Potassium

Non-nutritive sweetener, 130× sweeter than sucrose, used in gums, coffees

74
New cards

Aspartame

Artificial sweetener contraindicated in PKU due to phenylalanine content

75
New cards

Stevia

Natural sweetener, 30× sweeter than sucrose, non-toxic and safe

76
New cards

External Use Colorants

Restricted to external parts of body (not lips/mucosa)

77
New cards

Tartrazine

FD&C Yellow No. 5; Synthetic dye; may cause allergic reactions, cross-reacts with aspirin allergy

78
New cards

FD&C Lake

Pigments made from dye adsorbed on alumina hydrate; suitable for low-moisture formulations

79
New cards

Alcohol Vehicles

Self-sterilizing dosage forms, no preservatives needed

80
New cards

Aqueous Vehicles

Provide good microbial growth medium (require preservatives)

81
New cards

Ophthalmic Preservatives

Low-irritant preservatives used in eye drops (e.g., benzalkonium chloride, chlorobutanol, thimerosal)

82
New cards

Amaranth

FD&C Red No. 2; used extensively in drugs, cosmetics and foods. Causes cancer in rats.

83
New cards

Cocoa-flavored vehicles

Effective for masking the bitter taste of the drugs.

84
New cards

Fruits or citrus flavor

Combats sour/acid taste of the drugs.

85
New cards

Cinnamon, orange, raspberry

Makes salty tasting drugs more palatable.